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Abstract
Background: Previous studies have linked smaller kidney dimensions to increased blood pressure.
However, patients with Balkan Endemic Nephropathy (BEN), whose kidneys shrink during the
course of the disease, do not manifest increased blood pressure. The authors evaluated the
relationship between kidney cortex width, kidney length, and blood pressure in the offspring of
BEN patients and controls.
Methods: 102 offspring of BEN patients and 99 control offspring of non-BEN hospital patients in
the Vratza District, Bulgaria, were enrolled in a prospective study and examined twice (2003/04
and 2004/05). Kidney dimensions were determined using ultrasound, blood pressure was
measured, and medical information was collected. The parental disease of BEN was categorized
into three groups: mother, father, or both parents. Repeated measurements were analyzed with
mixed regression models.
Results: In all participants, a decrease in minimal kidney cortex width of 1 mm was related to an
increase in systolic blood pressure of 1.4 mm Hg (p = 0.005). There was no association between
kidney length and blood pressure. A maternal history of BEN was associated with an increase in
systolic blood pressure of 6.7 mm Hg (p = 0.03); paternal BEN, +3.2 mm Hg (p = 0.35); or both
parents affected, +9.9 mm Hg (p = 0.002). There was a similar relation of kidney cortex width and
parental history of BEN with pulse pressure; however, no association with diastolic blood pressure
was found.
Conclusion: In BEN and control offspring, a smaller kidney cortex width predisposed to higher
blood pressure. Unexpectedly, a maternal history of BEN was associated with average increased
systolic blood pressure in offspring.
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Background
There is a large body of evidence that patients with Balkan
Endemic Nephropathy (BEN), in contrast to other chronic
kidney diseases [1,2], do not manifest increased blood
pressure [3-9]. However, little is known about the devel-
opment of blood pressure in BEN patients, in particular,
whether increased blood pressure occurs in preclinical
stages. BEN was first characterized in the Vratza District,
Bulgaria in 1956 [10]. Later, similar nephropathies were
described in Yugoslavia in 1957 [3,10] and in Romania in
1961 [11]. As a result, in 1964, the disease was recognized
as a new nosological entity and was named Balkan
Endemic Nephropathy. BEN is a tubulo-interstitial kidney
disease that progresses slowly for many years. The final
disease stage is characterized by renal failure and shrink-
age of both kidneys to 3–4 cm in length [12]. Recent stud-
ies have shown that the offspring of BEN patients have
smaller kidney lengths or cortex widths [13,14], which
may be a marker of a reduced number of nephrons
[15,16]. Mackenzie et al. advanced the hypothesis that the
total nephron number is a factor determining susceptibil-
ity to increased blood pressure [17]. In addition, there is
evidence that the number of nephrons co-determines kid-
ney dimensions [18]. Lastly, Singh et al. and Zumrutdal et
al. have shown that decreased kidney dimensions are
associated with increased systolic blood pressure [16,19].
We conducted a prospective study in the Vratza District of
Bulgaria, a rural area, and measured the kidney cortex
width, kidney length, and blood pressure of the offspring
of BEN patients and control offspring at two time points,
one year apart. We hypothesize the following:
- A smaller kidney cortex width is related to a higher aver-
age systolic blood pressure and a higher pulse pressure.
- An offspring with parental history of BEN has a higher




In the period of October, 2003, to April, 2004, we
recruited adult offspring (102 study subjects) whose
father and/or mother were included in the Vratza Hospital
registry of BEN patients in 2001 and who resided in one
of three communities (Vratza, Bistretz, or Beli Izvor, Bul-
garia). The diagnosis of BEN in the parent generation is
based on three groups of criteria: epidemiological, clini-
cal/laboratory, and pathological/anatomical [20]. Regard-
ing epidemiology, the region is known to have a higher
prevalence of BEN, thus, the only individual criterion is
onset after the age of 20. Clinical and laboratory criteria
are a follows: obscure onset, chronic course, no sense of
edema, and normochromic type of anemia in more
advanced phases. Pathologically, an almost symmetrical
macroscopic shrinkage of the two kidneys was required in
the parent BEN population. A control group of equal size
comprised of adult offspring (99 study subjects) of non-
BEN hospitalized patients was enrolled in the study dur-
ing the same time period. Diagnoses in control parents
included diabetes mellitus, cardiovascular disorders, and
liver problems. Only three of the 99 parents had kidney
disorders (one paternal kidney cancer not related to BEN
and two maternal pyelonephritis cases). Subjects of both
groups were matched according to gender and ten-year
age groups. All participants provided written or verbal
consent (witnessed) through a procedure approved by the
Institutional Review Board (human-subject research com-
mittee) of the National Center of Public Health Protec-
tion, Sofia, Bulgaria. The population was enrolled and
examined in 2003/04 and investigated again in 2004/05,
which provided us with two repeated measurements one
year apart.
Interviews
We conducted face-to-face interviews with all participants
either in the hospital, or by visiting them in their home
villages. The standardized questionnaire asked for the
place of living, type of water supply, diet, smoking and
drinking habits, medical symptoms, family history of
BEN, family history of other kidney diseases and kidney
tumors, and occupational history.
Physical examination
The physical examination was performed by an experi-
enced physician with board certification in internal dis-
eases and nephrology. It was aimed at assessing the
general health status of the study subjects and at revealing
symptoms of BEN and/or other internal diseases. Blood
pressure was measured according to standards set by the
World Health Organization [21]. Participants were in the
seated position; three measurements were taken on the
right arm at 5 minute intervals. We recorded systolic and
diastolic blood pressure and calculated pulse pressure as
the difference between these two values.
Determination of the kidney sizes
Ultrasound investigations of both kidneys took 20–30
minutes. The patient was investigated lying on both the
left and right sides. After finding a suitable image, meas-
urements were taken. The longest dimension of the kid-
ney was determined. The thickness of the kidney
parenchyma (in the thinnest or minimal part), paren-
chyma structure, and the relationship of parenchyma and
pyelon were measured. Information gathered also
included the location, size, and morphology (cysts,
stones, and tumors) of the kidneys. The images were saved
electronically for future reference. The ultrasonographer
(AGB) worked in the Department of Image Diagnostics,BMC Nephrology 2006, 7:12 http://www.biomedcentral.com/1471-2369/7/12
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Vratza District Hospital, and was blinded to the clinical
status of the participant (BEN or control offspring).
Blood collection and analysis of lead
Blood samples were drawn in K2EDTA vacutainers. Lead
in blood was determined by using atomic absorption
spectrometry. A Model 4110 ZL atomic absorption spec-
trometer (Bodenseewerk Perkin-Elmer, Ueberlingen, Ger-
many) with a transverse heated graphite atomizer and
longitudinal Zeeman-effect background correction
equipped with an AS-72 autosampler, electrodeless dis-
charge lamps System II, software WinLab (Version 1.2)
and both "Standard"(Part No B 300-0643) and "End-
capped" (Part No B 300-0644) THGA tubes with inte-
grated platforms was used for direct electrothermal AAS
measurements. To measure lead, blood was diluted 10-
fold with 0.25% v/v Triton X-100; 10 µL of the sample and
25  µg of (NH4)2HPO4  as a chemical modifier were
injected in the THGA, pre-treated with 250 µg of zirco-
nium and 20 µg iridium. Matrix-matched calibrations
were applied [22]. Certified reference materials
(Seronorm Trace Elements Whole Blood, Level 1, Cat. No
201505, and Level 2, Cat. No 201605, Sero AS, Norway)
were used for internal laboratory control.
Statistical analyses
Outcome variables were diastolic, systolic blood pressure,
and pulse pressure. For descriptive purposes, we defined
moderate hypertension as a systolic blood pressure ≥150
mm Hg and a diastolic blood pressure ≥100 mm Hg.
However to investigate average increases, the explanatory
models used the three continuous outcome variables.
To answer the question whether minimal kidney cortex
width is related to higher blood pressure, we controlled
for potentially confounding factors such as gender, age,
history of smoking, diabetes mellitus, parental history of
hypertension or of Balkan Endemic Nephropathy, body
surface area, and blood lead level. For smoking, we cate-
gorized a subject as being a current smoker, ex-smoker, or
non-smoker. A parental history of high blood pressure fell
into one of three groups: mother, father, or both affected.
We asked for presence of diabetes mellitus in the first
investigation (2003/04) and for a new occurrence in the
second investigation. The body surface area (BSA) was cal-
culated as ([height * weight]/3600)2. This variable is used
in the model to control for the effect of weight and height
on kidney size and on blood pressure. In each investiga-
tion (2003/04 and 2004/05) the average kidney cortex
width and kidney length of both kidneys were used as pre-
dictors.
To test the hypothesis that offspring of BEN parents have
increased blood pressure, we grouped parental disease sta-
tus into three groups: mother, father, or both parents
affected. None of the comparison offspring fell into any of
these groups (reference). The effect of cortex width and
parental BEN status was tested in the same model.
In order to estimate the association of minimal kidney
width and parental history of BEN with blood pressure
based on repeated measurements, we applied linear
mixed models. Measurements of the two investigations
are not independent and mixed models allow adjusting
for within-participant effects [23]. The mixed model
assumes that the random effects and the error vector are
normally distributed, which was the case for the blood
pressure variables. SAS PROC MIXED was used to perform
the regression analysis [24]. We used Akaike information
criteria and the likelihood ratio test to examine the signif-
icance of serial correlation (in repeated statement) as well
as to model random effects, along with a suitable vari-
ance-covariance matrix structure.
To compare the agreement between measurements of
continuous variables in 2003/04 and 2004/05 we used
the intra-class correlation coefficient (ICC). This is the
between-subject minus the within-subject variance
divided by the sum of the two variances. The ICC quanti-
fies the proportion of total outcome variance that is due
to inter-individual variation.
Results
Of the 201 participants in the first investigations (2003/
04), 189 participated in the follow-up (2004/05, 94%).
Two were deceased, one moved out of the area, two could
not be contacted, and 7 decided not to participate further.
Of the 12 lost, 9 were offspring of BEN patients. Potential
risk factors show similar distributions in each of the two
investigations (Table 1). One participant had newly devel-
oped diabetes. Comparison offspring were about 1.5 to 2
cm taller than BEN offspring; however, the latter were on
average 1.5 kg heavier. Blood pressure seems to be higher
in BEN offspring: 30.4% were classified as having moder-
ate hypertension (systolic blood pressure ≥140 and/or
diastolic ≥90 mm Hg) in the investigation in 2003/04 and
33.3% in 2004/05 (Table 1). The prevalence of moderate
hypertension in our rural sample, with a mean age of 50
years, is only marginally lower than the proportion
reported in another study of urban population of the
same age in Bulgaria [25]. Also, offspring of BEN patients
reported more antihypertensive treatment in the year
before the investigation.
Figure 1 shows the agreement between the two systolic
blood pressure measurements one year apart. The intrac-
lass correlation coefficient (ICC) of 0.68 (lower 5% limit:
0.61) was good for systolic blood pressure, but lower for
diastolic blood pressure (ICC = 0.49, lower 5% limit:
0.39). For the minimal cortex width, the ICC was 0.66BMC Nephrology 2006, 7:12 http://www.biomedcentral.com/1471-2369/7/12
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(lower 5% limit: 0.58) and 0.92 for kidney length (lower
limit: 0.89). Blood lead concentration also showed good
agreement (ICC = 0.65, lower limit: 0.57).
The study population consists of 201 subjects that pro-
vided 388 observations (two measurements for most par-
ticipants, one year apart). When analyzing blood pressure
differences while controlling for confounders, cortex
width and parental BEN status had significant effects on
systolic and pulse pressure, but not on diastolic blood
pressure. A decrease in the minimal kidney cortex of 1 mm
was linearly related to an increase in systolic blood pres-
sure of 1.4 mm Hg (p = 0.005) and an increase of pulse
pressure of 1.1 mm Hg (p = 0.002).
Figure 2 shows the scatter plot of minimal cortex width
and pulse pressure using a cubic regression with 95% con-
fidence limits. A cubic regression fitted the observations
best when no other predictors were taken into considera-
tion. Within the boundaries of our measurements of the
cortex width there was no decrease in blood pressure once
the minimal kidney cortex width was 16 mm or larger.
Blood pressure started to increase when the width was
smaller than 16 mm.
A maternal history of BEN was associated with an
increased systolic blood pressure in offspring of 6.7 mm
Hg (p = 0.03), and when both parents had BEN, an
increased systolic blood pressure of 9.9 mm Hg (p =
0.002). There was no statistically significant effect of a
paternal history of BEN.
To investigate whether the use of antihypertensive medi-
cation had distorted our findings, we repeated the model
excluding those observations with antihypertensive drug
use. This reduced the number of repeated observation
from 388 to 322 (176 subjects), but did not change our
findings.
Discussion
Our findings show that a decrease of the minimal kidney
cortex width of 1 mm was related to an increase in systolic
Table 1: Characteristics of the Study Population of the Adult Offspring Study Cohort
Investigation in 2003/04 Investigation in 2004/05
Offspring of BEN 
patients, n = 102 (%)
Offspring of control 
patients, n = 99 (%)
Offspring of BEN 
patients, n = 93 (%)
Offspring of control 
patients, n = 96 (%)
Gender male 50.0 47.5 48.8 47.9
Smoking Current
smoker
39.2 34.3 38.7 35.4
Ex-smoker 22.6 12.1 21.5 12.5
Non-smoker 38.4 53.5 39.8 52.1
Diabetes Yes 7.8 6.1 5.4 7.3
Parental history of hypertension Mother 19.6 16.2 20.4 16.7
Father 13.7 16.2 15.1 16.7
Both 2.9 5.1 3.2 5.2
Parental history of BEN Mother 38.2 0 38.7 0
Father 25.2 0 25.8 0
Both 36.3 0 35.5 0
Moderate hypertension in the offspringξ 30.4 19.2 32.3 22.9
Antihypertensive medication 22.5 5.1 29.0 12.5
Mean (standard deviation) or median and 95% confidence interval†
Age (years) 47.3 (9.4) 49.6 (9.1) 50.4 (9.2) 48.8 (9.6)
Systolic blood pressure (mm Hg) 130.7 (20.1) 124.9 (17.6) 135.1 (23.0) 126.1 (19.1)
Diastolic blood pressure (mm Hg) 80.8 (12.2) 78.9 (10.5) 83.5 (14.0) 80.6 (12.5)
Pulse pressure $ (mm Hg) 49.3 (13.3) 46.2 (12.1) 51.5 (13.3) 45.5 (10.7)
Weight (kg) 75.8 (14.8) 73.6 (11.6) 73.3 (14.2) 71.9 (11.1)
Height (cm) 167.7 (8.5) 169.4 (7.7) 163.8 (9.0) 165.3 (7.7)
Body surface area # (m2) 1.87 (0.22) 1.86 (0.2) 1.82 (0.21) 1.81 (0.2)
Minimal width of the kidney cortex (mm) 15.5 (2.03) 15.9 (1.9) 15.2 (2.1) 15.6 (1.8)
Kidney length (mm) 116.7 (6.8) 119.6 (7.0) 117.3 (6.8) 119.2 (6.8)
Lead in whole blood (µg/L, median 
and 95% CI)¥
93.8 (50–205) 87.6 (42–225) 87.7 (41–210) 84 (39–203)
† A median was used if the variable was not normally distributed.
$ Difference of systolic minus diastolic blood pressure
¥ 95%CI – 95% confidence interval
# Body surface area = ([height * weight]/3600)2
ξ Systolic blood pressure ≥140 and/or diastolic ≥90 mm Hg.BMC Nephrology 2006, 7:12 http://www.biomedcentral.com/1471-2369/7/12
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blood pressure of 1.4 mm Hg. There was no association
between kidney length and blood pressure. A maternal
history of BEN was associated with a significant increase
in systolic blood pressure of 6.7 mm Hg, paternal BEN
with a non-significant increase of 3.2 mm Hg, and both
parents affected, a significant increase of 9.9 mm Hg. The
lack of association of either kidney cortex width or a
parental history of BEN with diastolic blood pressure may
either stem from the larger individual variance of this
parameter or may indicate that there is no such link.
In a study with healthy volunteers in England, Raman et
al. did not identify a clear pattern between measurements
of the right and left kidneys and blood pressure [26]. In
another population-based study, Paivansalo et al. found
that the kidneys of hypertensive women were slightly
larger (p < 0.08) [27]. To the contrary, comparing hyper-
tensive and normotensive Turkish patients, Zumrutdal et
al. found that kidney length and volume were signifi-
cantly smaller in hypertensive patients [19]. Thus, it is not
clear whether hypertension affects kidney dimensions or
vice versa.
For adult Aboriginals in Australia, Singh et al. found that
a 10 mL decrease in kidney volume was associated with a
0.5 mm Hg increase in systolic blood pressure [16]. The
study of Singh et al. did not provide information on cortex
width; in our study we do not have information on kidney
volume. To compare results, we expressed both findings
as a percent decrease in kidney dimensions. A 10 mL
decrease in kidney volume in the Australian study repre-
sents approximately a 5% decrease in volume (range: 62 –
267 mL). In our study of adult Caucasian offspring from
Bulgaria, a 5% decrease in the minimal cortex width (0.5
mm, range 10 – 20 mm) is associated with a 0.7 mm Hg
increase in blood pressure. Thus, both studies found a
similar effect of kidney dimensions on blood pressure.
Singh et al. also showed a cubic-type association between
kidney volume and systolic blood pressure. Similarly, we
have demonstrated a cubic regression between minimal
kidney cortex width and blood pressure; the threshold we
detected in our model, is approximately 16 mm of cortex
width. However, if we control for other variables in mixed
regression models, a straight line is also appropriate
(Table 2).
Mackenzie et al. posited the hypothesis that the total
nephron supply at birth is a factor in determining a sus-
ceptibility to increased blood pressure [17]. Given that
kidney dimensions correlate with the number of neph-
rons [18], our finding that minimal cortex width is signif-
icantly associated with systolic and pulse pressure
supports Mackenzie's hypothesis. In addition, we found
that, in offspring, maternal BEN is associated with
increased systolic and pulse pressure. In a prior report of
this project, we showed that a maternal but not a paternal
history of BEN is related to reduced cortex width in their
adult offspring [14]. The stronger role of maternal BEN in
offspring susceptibilities (cortex width and average blood
pressure) and the lack of paternal-related risks may indi-
cate, in our opinion, the importance of feto-maternal
interactions during pregnancy. Mothers who later develop
BEN do not yet have the disease during their childbearing
Scatterplot of minimal kidney cortex width with pulse pres- sure in the 2004/05 investigation (crude association; for  adjusted effects, see Table 2) Figure 2
Scatterplot of minimal kidney cortex width with pulse pres-
sure in the 2004/05 investigation (crude association; for 
adjusted effects, see Table 2). The straight line shows the 
estimated cubic association, the dotted lines show the 95% 
confidence limits.
Comparisons of systolic blood pressure measurements in  2003/04 and 2004/05 Figure 1
Comparisons of systolic blood pressure measurements in 
2003/04 and 2004/05.BMC Nephrology 2006, 7:12 http://www.biomedcentral.com/1471-2369/7/12
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years. However, they are likely to have developed precur-
sors of the disease before becoming pregnant, which,
however, must be sufficient in themselves to initiate a
higher risk in the offspring for having a smaller kidney
cortex width and increased systolic and pulse pressure.
Hence, a maternal history of BEN may have both a direct
and an indirect effect on blood pressure in offspring. Indi-
rectly, maternal BEN seems to decrease kidney cortex
width, which in turn increases blood pressure in adult off-
spring. Directly, maternal BEN seems to initiate regula-
tions likely to raise the average blood pressure in affected
offspring. However, hypertension is not a predominant
feature in BEN offspring. Thus, it is unlikely that the
reduction in kidney cortex width in BEN offspring results
from hypertension.
Renal mass is considered to contribute directly to the
development and maintenance of hypertension
[16,19,28]. Also renal scarring, an index of chronic dam-
age, has also been related to blood pressure [29]. Since we
have previously reported a reduced kidney cortex width in
BEN offspring [14], our finding that minimal cortex width
is related to blood pressure is in agreement with prior
reports.
However, in BEN patients, whose kidneys shrink, the lack
of increased blood pressure has been considered to be a
typical characteristic before the disease reaches its final
stage [3-9]. The reason for this unusual association has
never been explained. We were surprised to find that BEN
offspring had an average increased systolic blood pres-
sure, in particular related to a maternal history of BEN. In
agreement with our finding, Arsenovic et al. recently also
reported an increased prevalence of hypertension (20 out
of 47 persons) in BEN family members [30].
Since our data is based on adult offspring, we are uncer-
tain about the future development of blood pressure in
this group. There are three possibilities: (I) Offspring of
BEN patients will not develop BEN but maternal BEN may
lead to subclinical changes such as an increase in average
blood pressure. An argument against this option is that we
have found reduced kidney sizes and increased protein
excretion in the BEN offspring, which may be considered
as early signs of BEN [14]. (II) BEN offspring will develop
BEN and their higher average blood pressure will disap-
pear with the progression of BEN. One speculation is that
the juxtaglomerular cells become injured and thus the
renin-angiotensin system also is impared, which may pre-
vent hypertension. (III) A third option is that the reported
lack of hypertension in BEN patients was not based on sci-
entifically sound conclusions and needs to be revised.
Conclusion
We found that adult offspring of BEN patients have an
average increased blood systolic pressure and pulse pres-
sure, determined in two repeated measurement one year
apart. This is contrary to reports in BEN patients, who do
not have this characteristic. Surprisingly, the increase was
related to a maternal history of BEN, or a history of BEN
in both parents, but not to a paternal history alone.
Increased blood pressure was also associated with a reduc-
tion of the minimal width of the kidney cortex, but not
with a reduction in kidney length. In our understanding,
these findings emphasize the role of maternal priming in
determining susceptibility for increased blood pressure.
Balkan endemic nephropathy may serve as a model to bet-
ter understand the development of both kidney disorders
and their related blood pressures.
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